SMi’s conference on Biosimilars & Biobetters USA 2015 will offer effective strategies and solutions for developing cost effective biosimilars for the future, through a series of exciting discussions, presentations and workshops, delivered by true biosimilar leaders and industry pioneers.This year’s unrivalled speaker line up includes leading experts representing Sandoz (speaking on their first biosimilar approved by the FDA), ParExel, FDA, Merck Serono SA, Formycon AG, Dr. Reddy’s Laboratories, AGES Regulatory Agency, Janssen R&D, IMS Health, Norwegian Medicines Agency, Harvest Moon Pharmaceuticals USA, Austrian Agency for Health and Food Safety, MedImmune, Bristows LLP, Schwegman Lundbe4rg Woessner, Selecta Biosciences, STC Biologics, BioInsights Inc, amp BIosimilars AG (Germany)…Topics to be discussed include the regulatory landscape and pharmacovigilance of biosimilars, the BPCIA’s dispute resolution process, the technical challenges in biosimilars, biologics manufacturing, commercialisation strategies & improving market development unexpected in results in Immunogenicity testing and so much more.
Does this listing belong to your company? Click here to claim this listing.
Biosimilars and Biobetters USA
SMi's conference on Biosimilars & Biobetters USA 2015 will offer effective strategies and solutions for developing cost effective biosimilars for the future, through a series of exciting discussions,
|Website Link||Visit Link Here|